People · Operator
Named in public records as an officer, director or promoter · active 2017–2020 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aledade, Inc. | — | Healthtech | Series D+ | $662.6M | $3.5B | 2017 |
Charles Colligan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Colligan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| PATRICK CONWAY | 1 | 6 |
| Julie Sunderland | 1 | 5 |
| Robert Kocher | 1 | 5 |
| Bijan Salehizadeh | 1 | 5 |
| Mark McClellan | 1 | 3 |
| James Manzi | 1 | 2 |
| Paul Hennessy | 1 | 2 |
| John Doyle | 1 | 2 |
| Farzad Mostashari | 1 | 1 |
| Robert B. Kocher | 1 | 1 |
| Phuong Phillips | 1 | 1 |
| Michelle Ryan | 1 | 1 |
| James B. Manzi | 1 | 1 |
| David Blumenthal | 1 | 1 |
| Phyllis Yale | 1 | 1 |
| Matthew Kendall | 1 | 1 |
| Kendall Mat | 1 | 1 |
| Mat Kendall | 1 | 1 |
| Stephen B. Thau | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.